1. Home
  2. DSGN vs GRO Comparison

DSGN vs GRO Comparison

Compare DSGN & GRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • GRO
  • Stock Information
  • Founded
  • DSGN 2017
  • GRO 2006
  • Country
  • DSGN United States
  • GRO Canada
  • Employees
  • DSGN N/A
  • GRO N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • GRO
  • Sector
  • DSGN Health Care
  • GRO
  • Exchange
  • DSGN Nasdaq
  • GRO NYSE
  • Market Cap
  • DSGN 353.9M
  • GRO 371.9M
  • IPO Year
  • DSGN 2021
  • GRO 2024
  • Fundamental
  • Price
  • DSGN $6.25
  • GRO $8.70
  • Analyst Decision
  • DSGN Hold
  • GRO
  • Analyst Count
  • DSGN 3
  • GRO 0
  • Target Price
  • DSGN $7.00
  • GRO N/A
  • AVG Volume (30 Days)
  • DSGN 208.4K
  • GRO 40.4K
  • Earning Date
  • DSGN 11-07-2024
  • GRO 02-03-2025
  • Dividend Yield
  • DSGN N/A
  • GRO N/A
  • EPS Growth
  • DSGN N/A
  • GRO N/A
  • EPS
  • DSGN N/A
  • GRO N/A
  • Revenue
  • DSGN N/A
  • GRO N/A
  • Revenue This Year
  • DSGN N/A
  • GRO N/A
  • Revenue Next Year
  • DSGN N/A
  • GRO N/A
  • P/E Ratio
  • DSGN N/A
  • GRO N/A
  • Revenue Growth
  • DSGN N/A
  • GRO N/A
  • 52 Week Low
  • DSGN $2.25
  • GRO $8.25
  • 52 Week High
  • DSGN $7.77
  • GRO $15.00
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 52.38
  • GRO N/A
  • Support Level
  • DSGN $5.55
  • GRO N/A
  • Resistance Level
  • DSGN $6.45
  • GRO N/A
  • Average True Range (ATR)
  • DSGN 0.56
  • GRO 0.00
  • MACD
  • DSGN -0.04
  • GRO 0.00
  • Stochastic Oscillator
  • DSGN 57.67
  • GRO 0.00

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About GRO BRAZIL POTASH CORP

Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company includes focusing on the extraction and processing of potash ore from underground mine and selling and distributing the processed potash in Brazil.

Share on Social Networks: